Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.
D002247:Carbon Isotopes; D002264:Carboxylic Acids / Q000096:biosynthesis / Q000097:blood / Q000652:urine; D002395:Catecholamines / Q000096:biosynthesis; D002852:Chromatography, Ion Exchange; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D004298:Dopamine / Q000097:blood / Q000652:urine; D004837:Epinephrine / Q000097:blood / Q000652:urine; D004987:Ethers / Q000096:biosynthesis / Q000097:blood / Q000652:urine; D005243:Feces / Q000032:analysis; D005743:Gastrectomy; D005750:Gastric Juice / Q000032:analysis; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D007441:Intubation, Gastrointestinal; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D013997:Time Factors
D002247:Carbon Isotopes; D002264:Carboxylic Acids; D002395:Catecholamines; D004987:Ethers; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D004837:Epinephrine